Friday, October 12, 2018

Investorideas.com - #CryptoCorner: Market Stays Put with #XRP Correction, #ZRX Rallies with #Coinbase Adoption, Singapore's BK Global Consortium Buys $352 Million Stake in Bithumb

Investorideas.com - #CryptoCorner: Market Stays Put with #XRP Correction, #ZRX Rallies with #Coinbase Adoption, Singapore's BK Global Consortium Buys $352 Million Stake in Bithumb



#CryptoCorner: Market Stays Put with #XRP Correction, #ZRX Rallies with #Coinbase Adoption, Singapore's BK Global Consortium Buys $352 Million Stake in Bithumb

October 12th #CryptoCorner and Podcast sponsored by Crypto payment tech, #Flip @FlipToPay ($NXTD) and Genesis Exchange and Wallet App


Point Roberts, WA and Delta, BC - October 12, 2018 (Investorideas.com Newswire) Investorideas.com, a leader in crypto and blockchain investing news reports on what's driving the cryptocurrency markets with today's edition of Crypto Corner, now available in podcast.
Listen to today's Crypto Corner Podcast:

#CryptoCorner: Market Stays Put with #XRP Correction, ZRX Rallies with #Coinbase Adoption, Singapore's BK Global Consortium Buys $352 Million Stake in Bithumb

Subscribe to Podcast RSS feed:

Market Stays Put with XRP Correction, ZRX Rallies with Coinbase Adoption, Singapore's BK Global Consortium Buys $352 Million Stake in Bithumb and Gemini Announces Support for LTC

Following yesterday's $16 billion USD market cap drop, the crypto market appears to have stabilized somewhat heading into the weekend. Data from CoinMarketCap indicates that total market capitalization remains as it was 24 hours ago at $202 billion USD. Bitcoin (BTC) and Ether (ETH) are trading more or less the same as well at about $6300 USD and $197 USD, respectively. Notably, XRP has shown a strong correction, growing nearly 5 percent in the past 24 hours.
Another success story is the altcoin 0x (ZRX), which has seen 15 percent growth in the last day, gaining $68 million USD for market capitalization of $434 million USD at press time. This is due to its becoming available to trade on Coinbase Pro yesterday. A Coinbase blog post announced the news that trading was fully live with trading pairs including ZRX-USD, ZRX-BTC and ZRX-EUR initially available.
Bloomberg reports that Singapore-based BK Global Consortium has bought 50 percent plus one share of BTC Holding Co., the largest investor in the operator of one of South Korea's biggest crypto exchanges, Bithumb. BK, which is led by plastic surgeon and startup investor Kim Byung-gun, acquired the stake for 400 billion won ($352 million USD). A spokesperson said the transaction will be completed in February of 2019.
Crypto exchange Gemini announced via Medium that the platform will now offer buying and trading of Litecoin (LTC). Saturday, Oct 13 will be the first day users can deposit Litecoin into their Gemini accounts, while Tuesday will be the first day that trading becomes available. Gemini's VP of engineering, Eric Winer, also indicated that the company intended to launch Bitcoin Cash (BCH) trading today as well, but the possibility of forking has delayed their decision.
"We also had planned to announce support for Bitcoin Cash (BCH) today as well. However, there has been much uncertainty lately within the Bitcoin Cash community about one or more possible hard forks arriving in mid-November. Some of those forks lack the replay protection feature that would be required for Gemini to safely support Bitcoin Cash. Because of this situation, we are delaying our launch of Bitcoin Cash deposits, withdrawals, and trading until late November, after the forks have passed and we can evaluate the health of the Bitcoin Cash ecosystem. Until then, you may see some "coming soon" pages for Bitcoin Cash deposits, withdrawals, and trading on our website and APIs."
Sam Mowers, Investorideas
Read other editions of the Crypto Corner
Get the Crypto Corner News by email Get Crypto Corner News
Crypto Corner Sponsors:
Investorideas.com - NXT-ID Inc. (NASDAQ: NXTD) Subsidiary Fit Pay Flip<sup>TM</sup>
Flip™ is the creation of Fit Pay, Inc., a leading provider of cutting edge payment technology and a subsidiary of NXT-ID (<NASDAQ: NXTD). By leveraging the FitPay Payment Platform™, Flip enables cryptocurrency holders to seamlessly exchange their cryptocurrency for US dollars and store that value on a contactless payment device that can be used to make purchases at millions of retail locations. https://www.fliptopay.com/


Investorideas.com - GBT Genesis Blockchain Technologies
Genesis Exchange and Wallet App by Genesis Blockchain Technologies (GBT)
GBT is a powerful cryptocurrency centralized / decentralized exchange which will include a broad range of services and benefits from cryptocurrency and blockchain markets development, while avoiding complications and risks arising from crytocurrency ownership, transfer, and exchange.You can Download the Genesis Exchange and Wallet App at Google Play and on the Apple App Store. Learn more at http://www.mygenesis.io

More info on the sector:
Investor Ideas is positioning as a leader in blockchain and crypto content with its Bitcoin and Blockchain portals Bitcoinandblockchainstocks.com, Cryptocurrencyinvestorideas.com and Blockchaininvestorideas.com
For investors following the sector Investor Ideas has a comprehensive Bitcoin, Blockchain and Digital Currency Stocks Directory
Talk about the sector with other companies and investors- Join our LinkedIn Group Blockchain and Digital Currency Stocks and ICO's - Latest News and Commentary https://www.linkedin.com/groups/13560073
About Investorideas.com - News that Inspires Big Investing Ideas https://www.investorideas.com/
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column and the Cleantech and Climate Change Podcast .
The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.
Visit the Podcast page at Investorideas.com:
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure: this newsletter and podcast is sponsored content by featured companies NXt-ID (NASDAQ: NXTD) on behalf of Flip and GBT Technologies . More info: http://www.investorideas.com/About/News/Clientspecifics.asp Learn more about Investor ideas podcast and news publication services and costs https://www.investorideas.com/News-Upload/
Cryptocurrency Disclaimer
Investorideas.com news content is not meant to be a solicitation to buy or sell cryptocurrencies and Investorideas.com does not directly sell cryptocurrencies; but acts as a news and research resource for interested investors following the blockchain sector.
Copyright and ownership: Crypto Corner is an Investorideas.com content brand
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Learn more about our news, PR and social media services at Investorideas.com
Follow us on Twitter https://twitter.com/Investorideas
Contact Investorideas.com
800-665-0411

Posted by at No comments:

Investorideas.com - Investor Ideas adds Nasdaq #Biotech #IPOs and CSE #Mining IPO Stocks to Directories (NASDAQ: $ADIL), (NASDAQ: $ALLK) (NASDAQ: $AQST), (CSE: $ZX.C)

Investorideas.com - Investor Ideas adds Nasdaq #Biotech #IPOs and CSE #Mining IPO Stocks to Directories (NASDAQ: $ADIL), (NASDAQ: $ALLK) (NASDAQ: $AQST), (CSE: $ZX.C)



Join our smart investors - Get the best stock directories in blockchain, cannabis, crypto, AI, IoT, cleantech. Daily podcasts in cannabis and crpto. Just $99 a year





Investor Ideas adds Nasdaq #Biotech #IPOs and CSE #Mining IPO Stocks to Directories (NASDAQ: $ADIL), (NASDAQ: $ALLK) (NASDAQ: $AQST), (CSE: $ZX.C)


Point Roberts, WA and Delta, BC - September 21, 2018 (Investorideas.com Newswire) Investorideas.com, a global news source and leading investor resource announces this week's additions to its global stock directories in biotech and mining.
Investorideas.com is a go- to destination for retail investors and tracks companies in high-profile trading sectors and makes ongoing additions to its stock directories for its followers and members . (https://www.investorideas.com/membership/)
The newest companies in biotech are all Nasdaq IPO listings from within the past few weeks and include pharmaceutical, medical device and biopharma companies looking to treat a variety of diseases and unmet medical conditions/needs.
The latest mining company is a recent CSE listing that is exploring and developing properties in Quebec and BC, Canada.
New Biotech Companies
ADIAL PHARMACEUTICALS, INC. (NasdaqCM: ADIL) is a clinical-stage biopharmaceutical company focused on the development of treatments for addictions. The Company's lead investigational new drug candidate, AD04, is a genetically targeted therapeutic agent for the treatment of alcohol use disorder (AUD). A Phase 2b clinical trial of AD04 for the treatment of AUD showed promising results in reducing frequency of drinking, quantity of drinking and heavy drinking (all with statistical significance), and no overt safety concerns (there were no statistically significant serious adverse events reported). The Company plans to commence a Phase 3 clinical trial using AD04 for the potential treatment of AUD in subjects with certain target genotypes, which are to be identified using the Company's proprietary companion diagnostic genetic test. AD04 is also believed to have the potential to treat other addictive disorders such as opioid use disorder, gambling, and obesity.
ALLAKOS INC. (NasdaqGS:ALLK) is a clinical stage company developing antibodies that target immunomodulatory receptors present on immune effector cells involved in allergic, inflammatory, and proliferative diseases. The Company's lead antibody, AK002, targets Siglec-8, an inhibitory receptor selectively expressed on human mast cells and eosinophils. Inappropriately activated eosinophils and mast cells have been identified as key drivers in a number of severe diseases affecting the gastrointestinal tract, eyes, skin, lungs and other organs. AK002 has completed two Phase 1 trials, one in healthy volunteers and a single ascending dose trial in patients with indolent systemic mastocytosis. AK002 demonstrated pharmacodynamic activity in both trials and in the trial involving patients with indolent systemic mastocytosis, patients reported improvements in their symptoms. AK002 is being tested in a Phase 2 trial for the treatment of eosinophilic gastritis and eosinophilic gastroenteritis. In addition, Allakos is conducting multiple-dose trials with AK002 in chronic urticaria, indolent systemic mastocytosis, and severe allergic conjunctivitis.
AQUESTIVE THERAPEUTICS, INC. (NasdaqGM: AQST) is a specialty pharmaceutical company focused on identifying, developing and commercializing differentiated products to address unmet medical needs. Aquestive Therapeutics has a late-stage proprietary product pipeline focused on the treatment of CNS diseases, and is working to advance orally-administered complex molecules that it believes can be alternatives to invasively-administered standard of care therapies. As the leader in developing and delivering drugs via its PharmFilm® technology, Aquestive Therapeutics also collaborates with pharmaceutical partners to bring new molecules to market in differentiated and highly-marketable dosage forms.
CONSTELLATION PHARMACEUTICALS INC (NasdaqGS:CNST) is a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics that address serious unmet medical needs in patients with cancers associated with abnormal gene expression or drug resistance.  With a decade of experience in the field, the Company has a deep understanding of how epigenetic regulators modulate gene expression in cancer cells and in the tumor and immune microenvironment.  Constellation is translating these insights to advance the Company's two lead clinical programs, the EZH2 inhibitor CPI-1205 for metastatic castration-resistant prostate cancer and solid tumors and the BET inhibitor CPI-0610 for myelofibrosis, and to explore other novel targets for which cancer epigenetics may enhance outcomes over currently available treatment options.
CRINETICS PHARMACEUTICALS, INC. (NasdaqGS:CRNX) is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's lead product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly, an orphan disease affecting more than 25,000 people in the United States. The company is also developing other oral nonpeptide somatostatin agonists for hyperinsulinism and neuroendocrine tumors, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. Crinetics was founded by a team of scientists with a track record of endocrine drug discovery and development.
ESTABLISHMENT LABS HOLDINGS INC. (NasdaqCM:ESTA) is a global medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market, by designing, developing, manufacturing and marketing an innovative portfolio of silicone gel-filled breast implants, branded as Motiva Implants®, the centerpiece of the MotivaImagine® platform. Motiva Implants® are produced at two FDA compliant state-of-the-art facilities in Costa Rica and currently sold in over 60 countries through exclusive distributors or the Company's direct salesforce. In March 2018, Establishment Labs received approval for an investigational device exemption (IDE) from the FDA and initiated the Motiva Implant® clinical trial in the United States in April 2018. In addition to Motiva Implants®, Establishment Labs' product and technologies portfolio includes the Divina® 3D Simulation System, Puregraft and MotivaImage® Centers.
LIQUIDIA TECHNOLOGIES INC (NasdaqCM: LQDA) is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT® technology to transform the lives of patients. PRINT® is a particle engineering platform that enables precise production of uniform drug particles designed to improve the safety, efficacy and performance of a wide range of therapies. Currently, Liquidia is focused on the development of two product candidates for which it holds worldwide commercial rights: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia's lead product candidate, LIQ861, currently being evaluated in a Phase 3 clinical trial (INSPIRE), is designed to improve the therapeutic profile of treprostinil by enhancing deep-lung delivery and achieving higher dose levels than current inhaled therapies by using a convenient, disposable dry powder inhaler. LIQ865, for which Liquidia has recently completed a U.S. Phase 1b clinical trial, is designed to deliver sustained-release particles of bupivacaine, a non-opioid anesthetic, to treat local post-operative pain for three to five days through a single administration. In addition to developing its own product candidates, Liquidia collaborates with leading pharmaceutical companies to develop their own product candidates across a wide range of therapeutic areas, molecule types and routes of administration, leveraging Liquidia's PRINT® technology.
PROVENTION BIO, INC (NasdaqCM:PRVB) is a clinical-stage biopharmaceutical company leveraging a transformational drug development strategy that is focused on the prevention or interception of immune-mediated disease. Our diverse portfolio was assembled with product candidates that have undergone clinical testing but may have been underdeveloped or deprioritized assets at other companies. Provention's mission is to in-license, transform and develop clinical-stage, or nearly clinical-stage, therapeutic candidates targeting the high morbidity, mortality and escalating costs of autoimmune and inflammatory diseases including: type 1 diabetes (T1D), Crohn's disease, ulcerative colitis, lupus, and certain life-threating viral diseases.
REPLIMUNE GROUP, INC. (NasdaqGS:REPL) headquartered in Woburn, MA, was founded in 2015 to develop the next generation of "oncolytic immunotherapies" for the treatment of cancer. Replimune is developing novel, proprietary therapeutics intended to improve the direct cancer-killing effects of selective virus replication and the potency of the immune response to the tumor antigens released. The Company's Immulytic™ platform is designed to maximize systemic immune activation, in particular to tumor neoantigens, through robust viral mediated immunogenic tumor cell killing and the delivery of optimal combinations of immune-activating proteins to the tumor and draining lymph nodes. The approach is expected to be highly synergistic with immune checkpoint blockade and other approaches to cancer treatment. Replimune intends to progress these therapies rapidly through clinical development in combination with other immuno-oncology products with complementary mechanisms of action
RUBIUS THERAPEUTICS, INC. (NasdaqGS:RUBY) is a biopharmaceutical company pioneering the development of a new class of medicines called Red Cell Therapeutics™. The Company's proprietary RED PLATFORM™ was designed to genetically engineer and culture Red Cell Therapeutics™ that are selective, potent and ready-to-use cellular therapies for the potential treatment of several diseases across multiple therapeutic areas. Rubius' initial focus is to advance RCT™ product candidates for the treatment of rare diseases, cancer and autoimmune diseases by leveraging three distinct therapeutic modalities — cellular shielding, potent cell-cell interaction and tolerance induction
VACCINEX, INC. (NasdqGM: VCNX) is a clinical-stage immunotherapy company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders, with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington's disease. Vaccinex is based in Rochester, New York.
New Mining Companies
Zenith Exploration Inc. (CSE:ZX) is a resource exploration issuer that acquires and explores mineral properties. Zenith's principal property is in Quebec and its secondary property is in BC. The Company intends to explore and develop these properties.
The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast. 
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer and disclosure info: https://www.investorideas.com/About/Disclaimer.asp.
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Learn more about our news, PR and social media services at Investorideas.com
Follow us on Twitter https://twitter.com/Investorideas
To sponsor one of our podcasts or columns or be a guest call us today!
Contact Investorideas.com
800-665-0411

Posted by at No comments:

Investorideas.com - New #CSE-Listed #CannabisStocks Added to Investor Ideas; ( CSE: $PWR.C) ( CSE: $FONE.C) ( CSE: $NGW.C); Countdown to Legalization in Canada

Investorideas.com - New #CSE-Listed #CannabisStocks Added to Investor Ideas; ( CSE: $PWR.C) ( CSE: $FONE.C) ( CSE: $NGW.C); Countdown to Legalization in Canada



Join our smart investors - Get the best stock directories in blockchain, cannabis, crypto, AI, IoT, cleantech. Daily podcasts in cannabis and crpto. Just $99 a year





New #CSE-Listed #CannabisStocks Added to Investor Ideas; ( CSE: $PWR.C) ( CSE: $FONE.C) ( CSE: $NGW.C); Countdown to Legalization in Canada


Point Roberts, WA and Delta, BC - October 12, 2018 (Investorideas.com Newswire) Investorideas.com, a global news source and investor resource covering cannabis and hemp stocks announces this week's additions to its cannabis /hemp stock directory for investors following the sector.
Investorideas.com tracks cannabis and hemp stocks on the TSX, TSX.V, CSE, OTC, NYSE, NASDAQ, ASX and global stock exchanges and makes ongoing additions to its stock directories for its follower and members. (https://www.investorideas.com/membership/)
This week's new companies are all listed on the Canadian Stock Exchange (CSE) and include a real estate company investing in land assets, a company converting the largest commercial scale greenhouse in Nevada for cultivation, production, packaging, and processing of cannabis and related products and a medicinal and recreational cannabis company operating in the State of California.
Investorideas.com cannabis/marijuana and hemp news and investing content now includes our daily potcastsCM ; podcasts featuring cannabis news and stocks to watch plus insight from thought leaders and experts. Interviews have included Montel Williams, The Arcview Group, Electrum Partners and the CEO of Cronos Group Inc. (NASDAQ: CRON).

The cannabis stocks potcast (podcast) is also released with an accompanying written transcript. Learn more and sign up at https://www.investorideas.com/Audio/Potcasts.asp

To sponsor our daily podcast for the month or to be an expert guest please contact us!
This week's new Marijuana/Cannabis Stocks Added to the Investor cannabis stock directory:
Captiva Verde Land Corp. (CSE:PWR) is a sustainable real estate company that invests in land assets that contain green residential communities, disruptive manufacturing facilities, organic food production and Cannabis operations.
Flower One Holdings Inc. (CSE:FONE) is a company with strategic investments in the cannabis sector through its wholly-owned subsidiaries. FONE's wholly-owned subsidiaries are located in Nevada where it is currently converting the largest commercial scale greenhouse in the State. The 430,000 square foot facility will be used for cannabis cultivation as well as the processing, production and high-volume packaging of dry flower, cannabis oils, concentrates and infused products.
Next Green Wave Holdings Inc. (CSE: NGW) (formerly Crossgate Capital Corp.) is a vertically integrated premium medicinal and recreational cannabis company operating in the State of California, the world's largest cannabis market. Led by award-winning cannabis industry veteran Mike Jennings, an Industry innovator specializing in premium cannabis products. With 15.5 acres and plans for four facilities centrally located in Coalinga, California – allowing for state-wide reach across the lucrative California market.
For investors following the sector Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks. Visit directory.
Investorideas.com global stock directories are part of the membership program on the site, accessed either by login and password or available in PDF format. The directories include stocks trading on the TSX, OTC, NASDAQ, NYSE and other recognized global stock exchanges, giving retail investors a wide variety of stocks to review. https://www.investorideas.com/membership/
The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer and disclosure info: https://www.investorideas.com/About/Disclaimer.asp.
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Learn more about our news, PR and social media services at Investorideas.com
Follow us on Twitter https://twitter.com/Investorideas
To sponsor one of our podcasts or columns or be a guest call us today!
Contact Investorideas.com
800-665-0411


Marijuana / Hemp Stocks

Marijuana / Hemp Stocks

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory
Global Cannabis Investing - features Investor Ideas Cannabis news
Posted by at No comments:

Investorideas.com Newswire - #Tech News: Gopher (OTCQB: $GOPH) Files Mobile Sharing Database Patent

Investorideas.com Newswire - #Tech News: Gopher (OTCQB: $GOPH) Files Mobile Sharing Database Patent



#Tech News: Gopher (OTCQB: $GOPH) Files Mobile Sharing Database Patent

Technology Designed to Work with Its Granted Guardian Patch Patent

Investorideas Featured Company: Gopher Protocol, Inc. (OTC:GOPH)


San Diego, CA - October 12, 2018 (Investorideas.com Newswire) Gopher Protocol Inc. (OTCQB: GOPH) ("Gopher"), a company specializing in the creation of Internet of Things (IoT) and Artificial Intelligence enabled mobile technologies, including a global platform with both mobile and fixed solutions, filed on October 9, 2018 a mobile database patent, which technology is designed to work in conjunction with the Guardian Patch Patent, application serial number 16155093.
This patent seeks to protect one of Gopher's essential intellectual properties, which is the mobile database management system. Gopher's devices are designed to communicate with each other via Gopher gNET private, secured communication protocol. gNET protocol devices are enabled to share/exchange vast amount of data utilizing a proprietary method. In addition, information database objects are transferred and stored between the devices using this method developed by Gopher. This innovative database management system is designed to add another significant layer of cyber security to Gopher's network, further reducing the threat of hacking into the network. The database management system is structured to work in conjunction with Gopher's granted Patch patent.
"Gopher's technologies are working through shared database, which are carefully secured and protected within our network protocol," stated Dr. Danny Rittman, Gopher’s Chief Technology Officer. "In addition, our database system is capable of handling a significant level of information over our network, which is essential for real-time applications like autonomous driving, military/security applications and similar IoT applications. The system is designed to manage databases of all types including media, textual, graphical and secured communication information. The system works with our proprietary integrated circuit (IC) within mobile devices and is AI supervised. Working together with our IC and mobile software application, the system is capable of sharing all mobile database types with all other databases utilizing Gopher's ICs that are installed on other mobile devices, worldwide, utilizing our own private, secured, encrypted protocol. We believe this will a critical component of our network when established. Gopher intends to integrate its database sharing and management technology within all of its tracking and GEO devices for civil and military/security applications. In addition, our database management system is the key communication within our network, supervised by our Avant! AI engine. The patent application seeks to protect the system's key methodologies, concepts and approaches."
About Gopher Protocol Inc. (http://gopherprotocol.com)
Gopher Protocol Inc. (GOPH) ("Gopher") (http://gopherprotocol.com/) is a development-stage company which consider itself Native IoT creator, developing Internet of Things (IoT) and Artificial Intelligence enabled mobile technology. Gopher has a portfolio of Intellectual Property that when commercialized will include smart microchips, mobile application software and supporting cloud software. The system contemplates the creation of a global network. The core of the system will be its advanced microchip technology that can be installed in any mobile device worldwide. Gopher envisions this system as an internal, private network between all enabled mobile devices providing shared processing, advanced mobile database management/sharing and enhanced mobile features.
Corporate Site: http://gopherprotocol.com
Consumer and product website for Guardian Patch: http://www.guardianpatch.com/.
Forward-Looking Statements
Certain statements contained in this press release may constitute "forward-looking statements". Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company’s ability to raise capital on acceptable terms, if at all, the Company’s successful development of its products and the integration into its existing products and the commercial acceptance of the Company’s products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.
Contact:
Dr. Danny Rittman CTO
Gopher Protocol Inc.
Media: press@gopherprotocol.com
SOURCE: Gopher Protocol Inc.

Gopher Protocol, Inc. (OTCQB:GOPH) is a featured tech stock on Investorideas.com

Get News Alerts on Gopher Protocol, Inc.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GOPH is a PR, social media and publishing client and compensates Investorideas.com: More disclaimer and disclosure  info: https://www.investorideas.com/About/Disclaimer.asp, https://www.investorideas.com/About/News/Clientspecifics.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

TechSectorStocks.com - investing ideas in tech stocks- mobile payments, social media, AI and Robotics, Drone Stocks, GPS, Internet of Things (IoT)

Like Tech Stocks? View our Tech Stocks Directory
Posted by at No comments:

Thursday, October 11, 2018

Investorideas.com - #CryptoCorner: #Crypto Market Tumbles Along with #Dow and #Nasdaq, South Korea to Decide on ICOs in November, India Considering State-Backed Crypto and Bitfinex Suspends Fiat Deposits

Investorideas.com - #CryptoCorner: #Crypto Market Tumbles Along with #Dow and #Nasdaq, South Korea to Decide on ICOs in November, India Considering State-Backed Crypto and Bitfinex Suspends Fiat Deposits



#CryptoCorner: #Crypto Market Tumbles Along with #Dow and #Nasdaq, South Korea to Decide on ICOs in November, India Considering State-Backed Crypto and Bitfinex Suspends Fiat Deposits

Stocks discussed: (NYSE:HSBC)

October 11th #CryptoCorner and Podcast sponsored by Crypto payment tech, #Flip @FlipToPay ($NXTD) and Genesis Exchange and Wallet App


Point Roberts, WA and Delta, BC - October 11, 2018 (Investorideas.com Newswire) Investorideas.com, a leader in crypto and blockchain investing news reports on what's driving the cryptocurrency markets with today's edition of Crypto Corner, now available in podcast.
Listen to today's Crypto Corner Podcast:

#CryptoCorner: #Crypto Market Tumbles Along with #Dow and #Nasdaq, South Korea to Decide on ICOs in November, #India Considering State-Backed Crypto

Subscribe to Podcast RSS feed:

Crypto Market Tumbles Along with Dow and Nasdaq, South Korea to Decide on ICOs in November, India Considering State-Backed Crypto and Bitfinex Suspends Fiat Deposits

Stocks discussed: (NYSE:HSBC)

The crypto market took a tumble yesterday, losing some $16 billion USD and dropping from a total market cap of $216 billion USD to a low of $200 billion USD. At press time, it has bobbed back up to $202 billion USD, according to data from CoinMarketCap. Investors will have noticed that this reflects a similar plummet seen in the stock market yesterday, with the Dow Jones, Nasdaq and S&P 500 all in the red due in part to rising interest rates from the Fed. This interrupts a period, roughly a couple of weeks, of relative stability in the crypto market. Bitcoin (BTC) is down to $6296 USD at press time, a 4 percent loss, and Ether (ETH), XRP and Bitcoin Cash (BCH) suffered somewhat more severely with losses of 10.5 percent, 12 percent and 11.5 percent, respectively.
South Korean outlet The Investor reports that the government will decide its position on ICOs in November this year. Chief of the Office for Government Policy Coordination, Hong Nam-ki, affirmed that a decision would be made once survey data from local blockchain companies was factored into the government's deliberation.
"We have had several discussions (on ICOs). Once the survey results are in by end-October, we plan to finalize the government's stance."
An Indian finance ministry panel tasked with regulating the crypto space is considering a government backed cryptocurrency instead, according to local outlet Quartz. This was confirmed by an unnamed senior government official "privy to the discussions of the panel".
"We are evaluating the government-backed cryptocurrency and crypto-token. And we are looking to develop and encourage our own research and development of blockchain technology."
However, an executive privy to the meetings who requested anonymity, points out the inherent contradiction of a state-backed cryptocurrency.
"If a virtual currency is going to be backed by the government then it goes against the whole grain of such coins. These are essentially decentralised ledgers, and if the government or the RBI [Reserve Bank of India] is trying to control it, then it loses its meaning."
The Block reports that crypto exchange Bitfinex has suspended fiat deposits. Bitfinex denied speculation that they were insolvent last week, and claimed to be banking with HSBC (NYSE:HSBC) through a private account at Global Trading Solutions. The Block concludes that this account must no longer be active as fiat deposits are suspended, though the exchange "expects the situation to normalize within a week".
Sam Mowers, Investorideas
Read other editions of the Crypto Corner
Get the Crypto Corner News by email Get Crypto Corner News
Crypto Corner Sponsors:
Investorideas.com - NXT-ID Inc. (NASDAQ: NXTD) Subsidiary Fit Pay Flip<sup>TM</sup>
Flip™ is the creation of Fit Pay, Inc., a leading provider of cutting edge payment technology and a subsidiary of NXT-ID (<NASDAQ: NXTD). By leveraging the FitPay Payment Platform™, Flip enables cryptocurrency holders to seamlessly exchange their cryptocurrency for US dollars and store that value on a contactless payment device that can be used to make purchases at millions of retail locations. https://www.fliptopay.com/


Investorideas.com - GBT Genesis Blockchain Technologies
Genesis Exchange and Wallet App by Genesis Blockchain Technologies (GBT)
GBT is a powerful cryptocurrency centralized / decentralized exchange which will include a broad range of services and benefits from cryptocurrency and blockchain markets development, while avoiding complications and risks arising from crytocurrency ownership, transfer, and exchange.You can Download the Genesis Exchange and Wallet App at Google Play and on the Apple App Store. Learn more at http://www.mygenesis.io

More info on the sector:
Investor Ideas is positioning as a leader in blockchain and crypto content with its Bitcoin and Blockchain portals Bitcoinandblockchainstocks.com, Cryptocurrencyinvestorideas.com and Blockchaininvestorideas.com
For investors following the sector Investor Ideas has a comprehensive Bitcoin, Blockchain and Digital Currency Stocks Directory
Talk about the sector with other companies and investors- Join our LinkedIn Group Blockchain and Digital Currency Stocks and ICO's - Latest News and Commentary https://www.linkedin.com/groups/13560073
About Investorideas.com - News that Inspires Big Investing Ideas https://www.investorideas.com/
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column and the Cleantech and Climate Change Podcast .
The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.
Visit the Podcast page at Investorideas.com:
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure: this newsletter and podcast is sponsored content by featured companies NXt-ID (NASDAQ: NXTD) on behalf of Flip and GBT Technologies . More info: http://www.investorideas.com/About/News/Clientspecifics.asp Learn more about Investor ideas podcast and news publication services and costs https://www.investorideas.com/News-Upload/
Cryptocurrency Disclaimer
Investorideas.com news content is not meant to be a solicitation to buy or sell cryptocurrencies and Investorideas.com does not directly sell cryptocurrencies; but acts as a news and research resource for interested investors following the blockchain sector.
Copyright and ownership: Crypto Corner is an Investorideas.com content brand
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Learn more about our news, PR and social media services at Investorideas.com
Follow us on Twitter https://twitter.com/Investorideas
Contact Investorideas.com
800-665-0411
Posted by at No comments:
Subscribe to: Posts (Atom)